drugset / Trial / NCT00838630
Cilostazol 100 mg Tablet Formulations Under Fasting Conditions
RandomizedCrossoverOpen-labelOther
Summary
The objective of this randomized, single-dose, two-way evaluation is to compare the bioequivalence of a test cilostazol formulation to an equivalent oral dose of the commercially available cilostazol in a test population of 36 adult subjects under fasting conditions.
Timeline
- Start
- 2003-11
- Primary completion
- 2003-11
- Completion
- 2003-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cilostazol | Small molecule | 100 mg | Oral |
Indications
No indication recorded.